PE20000887A1 - "PROGESTAGEN ONLY" TYPE CONTRACEPTIVE EQUIPMENT THAT ALLOWS GOOD CYCLE CONTROL - Google Patents
"PROGESTAGEN ONLY" TYPE CONTRACEPTIVE EQUIPMENT THAT ALLOWS GOOD CYCLE CONTROLInfo
- Publication number
- PE20000887A1 PE20000887A1 PE1999000799A PE00079999A PE20000887A1 PE 20000887 A1 PE20000887 A1 PE 20000887A1 PE 1999000799 A PE1999000799 A PE 1999000799A PE 00079999 A PE00079999 A PE 00079999A PE 20000887 A1 PE20000887 A1 PE 20000887A1
- Authority
- PE
- Peru
- Prior art keywords
- progestagen
- cycle control
- good cycle
- allows good
- type contraceptive
- Prior art date
Links
- WAHQVRCNDCHDIB-QZYSPNBYSA-N [(3s,8r,9s,10r,13s,14s,17r)-17-acetyl-17-acetyloxy-6,10,13-trimethyl-1,2,3,8,9,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-yl] 3-cyclopentylpropanoate Chemical compound O([C@@H]1C=C2C(C)=C[C@H]3[C@@H]4CC[C@]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)(OC(=O)C)C(C)=O)C(=O)CCC1CCCC1 WAHQVRCNDCHDIB-QZYSPNBYSA-N 0.000 title abstract 5
- 239000000583 progesterone congener Substances 0.000 title abstract 5
- 239000003433 contraceptive agent Substances 0.000 title abstract 3
- 230000002254 contraceptive effect Effects 0.000 title abstract 3
- WWYNJERNGUHSAO-XUDSTZEESA-N (+)-Norgestrel Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 WWYNJERNGUHSAO-XUDSTZEESA-N 0.000 abstract 1
- YJSTYQGZKJHXLN-OLGWUGKESA-N (8r,9s,10r,13s,14s,17r)-17-ethynyl-17-hydroxy-13-methyl-11-methylidene-2,6,7,8,9,10,12,14-octahydro-1h-cyclopenta[a]phenanthren-3-one Chemical compound O=C1CC[C@@H]2[C@H]3C(=C)C[C@](C)([C@](C=C4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 YJSTYQGZKJHXLN-OLGWUGKESA-N 0.000 abstract 1
- 229960004976 desogestrel Drugs 0.000 abstract 1
- RPLCPCMSCLEKRS-BPIQYHPVSA-N desogestrel Chemical compound C1CC[C@@H]2[C@H]3C(=C)C[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 RPLCPCMSCLEKRS-BPIQYHPVSA-N 0.000 abstract 1
- 210000004696 endometrium Anatomy 0.000 abstract 1
- SIGSPDASOTUPFS-XUDSTZEESA-N gestodene Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](C=C4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 SIGSPDASOTUPFS-XUDSTZEESA-N 0.000 abstract 1
- 229960005352 gestodene Drugs 0.000 abstract 1
- 229960004400 levonorgestrel Drugs 0.000 abstract 1
- 230000009466 transformation Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE REFIERE A UN KIT ANTICONCEPTIVO QUE COMPRENDE MEDIOS PARA LA ADMINISTRACION DIARIA DE PROGESTAGENO, CARACTERIZADO POR ESTAR DIVIDIDOS EN DOS FASES: I) ADMINISTRACION DIARIA DE 10 A 20 DIAS DE UN PROGESTAGENO EN UNA CANTIDAD LO MAS BAJA POSIBLE PARA INHIBIR LA OVULACION; Y, II) ADMINISTRACION DIARIA AL MENOS DURANTE 7 DIAS DE UN PROGESTAGENO EN UNA CANTIDAD QUE ES AL MENOS EL DOBLE DE LA FASE I), PERO NO MAS BAJA QUE LA DOSIS REQUERIDA PARA CAUSAR LA TRANSFORMACION DEL ENDOMETRIO. DONDE, EL PROGESTAGENO SE SELECCIONA DEL GRUPO CONSISTENTE EN DESOGESTREL, ORG 30659, LEVONORGESTREL Y GESTODENE. ASIMISMO, I) Y II) COMPRENDEN 14 UNIDADES DE DOSIFICACION DIARIAS. CON ESTE REGIMEN SE OBTIENE UN BUEN CONTROL DEL CICLO Y EFICACIA ANTICONCEPTIVAIT REFERS TO A CONTRACEPTIVE KIT THAT INCLUDES MEANS FOR THE DAILY ADMINISTRATION OF PROGESTAGEN, CHARACTERIZED BY BEING DIVIDED INTO TWO PHASES: I) DAILY ADMINISTRATION OF 10 TO 20 DAYS OF A PROGESTAGEN IN AN AMOUNT OF THE LOWEST POSSIBLE; AND, II) DAILY ADMINISTRATION FOR AT LEAST 7 DAYS OF A PROGESTAGEN IN AN AMOUNT THAT IS AT LEAST DOUBLE OF PHASE I), BUT NOT LOWER THAN THE DOSE REQUIRED TO CAUSE THE TRANSFORMATION OF THE ENDOMETRIUM. WHERE THE PROGESTAGEN IS SELECTED FROM THE GROUP CONSISTING OF DESOGESTREL, ORG 30659, LEVONORGESTREL AND GESTODENE. ALSO, I) AND II) INCLUDE 14 DAILY DOSAGE UNITS. WITH THIS REGIME, GOOD CYCLE CONTROL AND CONTRACEPTIVE EFFECTIVENESS IS OBTAINED
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98202699 | 1998-08-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20000887A1 true PE20000887A1 (en) | 2000-09-15 |
Family
ID=8234025
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1999000799A PE20000887A1 (en) | 1998-08-11 | 1999-08-09 | "PROGESTAGEN ONLY" TYPE CONTRACEPTIVE EQUIPMENT THAT ALLOWS GOOD CYCLE CONTROL |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU5619399A (en) |
| PE (1) | PE20000887A1 (en) |
| WO (1) | WO2000009136A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2745541C (en) * | 2008-12-12 | 2016-11-08 | Laboratoire Hra-Pharma | A method for contraception |
| AU2010237120B8 (en) | 2009-04-14 | 2015-11-26 | Laboratoire Hra-Pharma | Method for on-demand contraception |
| EP2730284A1 (en) * | 2012-11-12 | 2014-05-14 | Naari AG | Levonorgestrel-only-composition for optimized oral contraception with defined levonorgestrel content, dosage regimen and pharmaceutical preparation |
| US11679114B2 (en) * | 2021-07-26 | 2023-06-20 | Navad Life Sciences Pte | Progestogen-only oral contraception |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4066757A (en) * | 1973-03-26 | 1978-01-03 | Ortho Pharmaceutical Corporation | Oral contraceptive regimen |
| IE71202B1 (en) * | 1990-12-17 | 1997-02-12 | Akzo Nv | Progestagen-only contraceptive |
| DE4227989A1 (en) * | 1992-08-21 | 1994-06-09 | Schering Ag | Agent for transdermal application containing 3-keto-desogestrel |
-
1999
- 1999-08-04 AU AU56193/99A patent/AU5619399A/en not_active Abandoned
- 1999-08-04 WO PCT/EP1999/005610 patent/WO2000009136A1/en not_active Ceased
- 1999-08-09 PE PE1999000799A patent/PE20000887A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU5619399A (en) | 2000-03-06 |
| WO2000009136A1 (en) | 2000-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2181770T3 (en) | COMBINED PHARMACEUTICAL FORMULATION FOR HORMONAL CONTRACEPTION. | |
| EA200600964A1 (en) | PHARMACEUTICAL PREPARATION FOR CONTINUOUS HORMONAL TREATMENT DURING A LONGER LONGER THAN 21-4 DAYS, INCLUDING TWO ESTROGEN AND / OR PROGESTINE COMPOSITIONS | |
| ES2190472T3 (en) | TRANSDERMIC PATCH FOR THE ADMINISTRATION OF 17-DEACETIL NORGESTIMATO, ONLY OR IN COMBINATION WITH A STROGEN. | |
| PL182544B1 (en) | Agent for and method of performing hormonal contraception and/or treating acne | |
| ES2087964T3 (en) | LOW ESTROGEN ORAL CONTRACEPTIVES. | |
| CA2468748A1 (en) | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology | |
| BR9916579A (en) | Three-phase oral contraceptive | |
| AR031563A1 (en) | A PHARMACEUTICAL COMPOSITION FOR EMPLOYMENT IN THE TREATMENT OF MENOPAUSIC OR POSMENOPAUSIC DISORDERS OF STROGENS AND MEDROXIPROGESTERONE ACETATE, A PHARMACEUTICAL DOSAGE UNIT AND USE OF A CONJUGATED STRAGEN COMBINATION OF UTROGRAPHIC MANIFORM | |
| RS50262B (en) | PHARMACEUTICAL COMBINATION OF ETHINYLESTRADIOL AND DROSPIRENONE FOR ADMINISTRATION AS CONTRACEPTIVE | |
| NO986104L (en) | Progesterone-anti-progesterone regimens | |
| PE20060485A1 (en) | CONTRACEPTIVE REGIMES WITH PROGESTERONE RECEPTOR ANTAGONISTS AND KITS | |
| ES2087237T3 (en) | PROGESTOGEN AS A SOLE CONTRACEPTIVE. | |
| MXPA05005781A (en) | Combination of ibuprofen and oxycodone for acute pain relief. | |
| BR0009476A (en) | Immunomodulatory steroids, in particular 16 alpha-bromoepiandrosterone hemhydrate | |
| PE20000887A1 (en) | "PROGESTAGEN ONLY" TYPE CONTRACEPTIVE EQUIPMENT THAT ALLOWS GOOD CYCLE CONTROL | |
| PE20031047A1 (en) | TREATMENT OF POST-MENOPAUSAL PATIENTS IN PATIENTS WITH BREAST CANCER | |
| ES2348038T5 (en) | Polyphasic preparation for contraception based on a natural estrogen | |
| NO20061937L (en) | Extended three-phase prevention course | |
| NZ504351A (en) | Contraceptive kit comprising progestogen and anti-progestogen and use in treating bleeding induced by a progestogen-only contraceptive regimen | |
| UY39895A (en) | Method for treating endometriosis and providing effective contraception | |
| KR960700726A (en) | METHOD OF PREVENTING OF INHIBTING FERTILIZATION | |
| UY26966A1 (en) | USE OF ANTIPROGESTINES FOR THE INDUCTION OF APOPTOSIS IN A CELL | |
| ECSP993091A (en) | CONTRACEPTIVE REGIME OF THE "PROGESTAGEN ONLY" TYPE WHICH ALLOWS A GOOD CONTROL OF THE CYCLE AND CONTRACEPTIVE EFFECTIVENESS, WHERE THE PROGESTAGEN IS SUPPLIED IN TWO PHASES | |
| PE20070555A1 (en) | USE OF ESTRADIOL VALERATE IN COMBINATION WITH DIENOGEST FOR THE ORAL THERAPY OF DYSFUNCTIONAL UTERINE HEMORRHAGE CONNECTED WITH AN ORAL CONTRACEPTION | |
| KR960701642A (en) | METHOD AND COMPOSITION FOR TREATMENT OF OSTEOPOROSIS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |